However, whether combining intratumoral RNF43 expression with TAMs could increase the prognostic accuracy for ccRCC patients by combining with the current clinical indicators like TNM stage remain unclear. The gene discussed is RNF43; the disease is nonpapillary renal cell carcinoma.